Petrek, Hannah
Batra, Neelu
Ho, Pui Yan
Tu, Mei-Juan
Yu, Ai-Ming http://orcid.org/0000-0003-1441-4012
Funding for this research was provided by:
National Cancer Institute (R01CA225958)
National Institute of General Medical Sciences (R01GM113888)
Article History
Received: 26 February 2019
Revised: 7 May 2019
Accepted: 15 May 2019
First Online: 11 June 2019
Compliance with ethical standards
:
: The authors confirm that the article does not contain any studies with human participants or animals.
: The authors are named inventors of patent applications related to RNA bioengineering technology and therapeutics that are owned by the UC Davis, and Dr. Yu is a founder of AimRNA, Inc., which has an agreement to license the intellectual property. All other authors declare that they have no conflict of interest.